US private equity group Horizon Capital has made an undisclosed investment in marketing technology company Viseven, which serves the pharma and life sciences sectors.
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Nataliya Andreychuk, CEO of Viseven, about her personal battle with breast cancer.
Artificial intelligence is transforming nearly every industry these days, and in biopharma that goes for every part of the business -- from research and development to marketing and communi
Selective serotonin reuptake inhibitors (SSRIs) are the first-line drug therapy of choice for most people suffering from depression but often fail to work effectively.
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.